Yazici Y - Search Results

1

Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis.

Yazici Y, Yazici H. Yazici Y, et al. Among authors: yazici h. Clin Exp Rheumatol. 2008 May-Jun;26(3):449-52. Clin Exp Rheumatol. 2008. PMID: 18578967

2

Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritis.

Yazici H, Mat C, Deniz S, Iscimen A, Yurdakul S, Tuzun Y, Hekim N, Yazici Y. Yazici H, et al. Among authors: yazici y. Clin Exp Rheumatol. 1987 Oct-Dec;5(4):371-4. Clin Exp Rheumatol. 1987. PMID: 2964318

3

The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study.

Ince A, Yazici Y, Hamuryudan V, Yazici H. Ince A, et al. Among authors: yazici h, yazici y. Clin Rheumatol. 1996 Sep;15(5):491-4. doi: 10.1007/BF02229648. Clin Rheumatol. 1996. PMID: 8894364 Clinical Trial.

4

Hidden 19S IgM rheumatoid factors in Turkish patients with juvenile rheumatoid arthritis.

Ince A, Akhter IM, Moore TL, Basaran M, Yazici Y, Ozdogan H. Ince A, et al. Among authors: yazici y. J Rheumatol. 1998 Jan;25(1):190-2. J Rheumatol. 1998. PMID: 9458234 No abstract available.

5

Elderly-onset rheumatoid arthritis.

Yazici Y, Paget SA. Yazici Y, et al. Rheum Dis Clin North Am. 2000 Aug;26(3):517-26. doi: 10.1016/s0889-857x(05)70154-x. Rheum Dis Clin North Am. 2000. PMID: 10989510 Review.

6

A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.

Yazici Y, Erkan D, Lockshin MD. Yazici Y, et al. Clin Exp Rheumatol. 2000 Nov-Dec;18(6):732-4. Clin Exp Rheumatol. 2000. PMID: 11138337 Clinical Trial.

7

VATER association: is it recognised by rheumatologists?

Erkan D, Lam LA, Yazici Y, Magid SK. Erkan D, et al. Among authors: yazici y. Clin Rheumatol. 2001;20(2):128-31. doi: 10.1007/s100670170083. Clin Rheumatol. 2001. PMID: 11346225

8

Morning stiffness: how common is it and does it correlate with physician and patient global assessment of disease activity?

Yazici Y, Erkan D, Peterson MG, Kagen LJ. Yazici Y, et al. J Rheumatol. 2001 Jun;28(6):1468-9. J Rheumatol. 2001. PMID: 11409149 No abstract available.

9

Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.

Yazici Y, Erkan D, Lockshin MD. Yazici Y, et al. Clin Exp Rheumatol. 2002 Jan-Feb;20(1):115. Clin Exp Rheumatol. 2002. PMID: 11892697 Clinical Trial. No abstract available.

10

Decreased flares of rheumatoid arthritis during the first year of etanercept treatment: further evidence of clinical effectiveness in the "real world".

Yazici Y, Erkan D, Kulman I, Belostocki K, Harrison MJ. Yazici Y, et al. Ann Rheum Dis. 2002 Jul;61(7):638-40. doi: 10.1136/ard.61.7.638. Ann Rheum Dis. 2002. PMID: 12079908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results